Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
1.
Bioorg Med Chem Lett ; 11(9): 1205-10, 2001 May 07.
Article in English | MEDLINE | ID: mdl-11354378

ABSTRACT

The overstimulation of excitatory amino acid receptors such as the glutamate AMPA receptor has been implicated in the physiopathogenesis of epilepsy as well as in acute and chronic neurodegenerative disorders. An original series of readily water soluble 4-oxo-10-substituted-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives was synthesized. The most potent derivative 6a exhibited nanomolar binding affinity (IC50 = 35nM) and antagonist activity (IC50 = 6nM) at ionotropic AMPA receptor. This compound also demonstrated potent anticonvulsant properties in MES in mice and rats with long durations of action with ED50 values in the 1-3 mg/kg dose range following ip and iv administration.


Subject(s)
Anticonvulsants/chemical synthesis , Anticonvulsants/pharmacology , Carboxylic Acids/chemical synthesis , Carboxylic Acids/pharmacology , Pyrazines/chemical synthesis , Pyrazines/pharmacology , Receptors, AMPA/antagonists & inhibitors , Animals , Dose-Response Relationship, Drug , Electroshock , Injections, Intraperitoneal , Injections, Intravenous , Isoquinolines/pharmacology , Mice , Quinoxalines/pharmacology , Rats , Structure-Activity Relationship , Tetrazoles/pharmacology , Xenopus
2.
Bioorg Med Chem Lett ; 11(2): 127-32, 2001 Jan 22.
Article in English | MEDLINE | ID: mdl-11206442

ABSTRACT

A novel series of 2- and 9-disubstituted heterocyclic-fused 4-oxo-indeno[1,2-e]pyrazin derivatives was synthesized. One of them, the 9-(1H-tetrazol-5-ylmethyl)-4-oxo-5,10-dihydroimidazo[1,2-a]indeno[1,2-e]pyrazin-2-yl phosphonic acid 4i exhibited a strong and a selective binding affinity for the AMPA receptor (IC50 = 13 nM) and demonstrated potent antagonist activity (IC50 = 6nM) at the ionotropic AMPA receptor. This compound also displayed good anticonvulsant properties against electrically-induced convulsions after ip and iv administration with ED50 values between 0.8 and 1 mg/kg. Furthermore, a strong increase in potency was observed when given iv 3 h before test (ED50 = 3.5 instead of 25.6 mg/kg for the corresponding 9-carboxymethyl-2-carboxylic acid analogue). These data confirmed that there is an advantage in replacing the classical carboxy substituents by their bioisosteres such as tetrazole or phosphonic acid groups.


Subject(s)
Excitatory Amino Acid Antagonists/chemical synthesis , Excitatory Amino Acid Antagonists/pharmacology , Pyrazinamide/pharmacology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/antagonists & inhibitors , Animals , Anticonvulsants/chemical synthesis , Anticonvulsants/pharmacology , Combinatorial Chemistry Techniques , Disease Models, Animal , Excitatory Amino Acid Antagonists/chemistry , Imidazoles/chemical synthesis , Imidazoles/pharmacology , Inhibitory Concentration 50 , Male , Mice , Oocytes/drug effects , Pyrazinamide/analogs & derivatives , Pyrazinamide/chemical synthesis , Pyrazinamide/chemistry , Pyrazines/chemical synthesis , Pyrazines/pharmacology , Receptors, AMPA/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Seizures/chemically induced , Seizures/drug therapy , Seizures/prevention & control , Structure-Activity Relationship
3.
Expert Opin Investig Drugs ; 10(7): 1207-9, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11772244

ABSTRACT

In recent years, several strategies that selectively inhibit pro-inflammatory cytokines, have yielded effective protein-based therapies for inflammatory disorders, validating the therapeutic hypothesis that intervention in cytokine signalling can provide clinical benefit. However, these protein-based products must be administered by injection, a constraint associated with inconvenience, adverse effects and expense for patients, caregivers and insurers. Besides interfering with the effects of cytokines such as TNF-alpha or IL-1beta that have already been produced, inhibition of pro-inflammatory cytokine production or signalling with low-molecular weight orally-active drugs would combine the convenience of conventional pharmaceuticals with the focused efficacy of the protein therapies. Reducing IL-1beta and IL-18 production by inhibition of IL-1beta converting enzyme (ICE, caspase-1) is one promising strategy because of the key roles of these cytokines in many inflammatory diseases. Pralnacasan, the first orally available, potent and selective ICE inhibitor to enter clinical trials, is currently under investigation in rheumatoid arthritis.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Caspase Inhibitors , Enzyme Inhibitors/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Disease Models, Animal , Enzyme Inhibitors/therapeutic use , Humans , Interleukin-1/metabolism , Interleukin-18/metabolism
4.
Bioorg Med Chem ; 8(8): 2211-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11003165

ABSTRACT

Water soluble 8-methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e]pyraz ine-4-one 4 represents a novel class of highly potent and selective AMPA receptors antagonists with in vivo activity. The dextrorotatory isomer (+)-4 was found to display the highest affinity with an IC50 of 10 nM. It also exhibited very good anticonvulsant effects after i.p., s.c. and i.v. administration in mice subjected to electrical convulsions (MES) and i.p. in audiogenic seizure-e in DBA/2 mice (ED50's < or = 10 mg/kg).


Subject(s)
Anticonvulsants/chemical synthesis , Imidazoles/chemistry , Imidazoles/chemical synthesis , Pyrazines/chemistry , Pyrazines/pharmacology , Receptors, AMPA/antagonists & inhibitors , Animals , Anticonvulsants/chemistry , Anticonvulsants/metabolism , Anticonvulsants/pharmacology , Brain Chemistry , Cerebral Cortex/metabolism , Imidazoles/metabolism , Kainic Acid/pharmacology , Male , Mice , Microinjections , Molecular Structure , Oocytes/physiology , Patch-Clamp Techniques , Pyrazines/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Radioligand Assay , Rats , Stereoisomerism , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism
5.
J Med Chem ; 43(12): 2371-81, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10882363

ABSTRACT

Indeno¿1,2-bpyrazin-2,3-diones have been identified as a novel series of potent ligands on the glycine site of the NMDA receptor. To improve their in vivo activities, an acetic acid-type side chain was introduced to the 5-position, giving water-soluble compounds when formulated as the sodium salt (>10 mg/mL). Introduction of a chlorine atom in the 8-position led to a dramatic improvement of anticonvulsant activity and this was surprising since this change did not improve binding affinity. A plausible explanation is a reduced recognition by a Na(+),K(+)-ATPase active transport system responsible for the excretion of these compounds from the brain and kidney. This promising new chemical series led to the optically active isomer (-)-10i (RPR 118723), a glycine/NMDA antagonist with nanomolar binding affinity and in vivo activity in animal model of convulsions and electrophysiology at doses in the range of 2-3 mg/kg following iv administration.


Subject(s)
Excitatory Amino Acid Antagonists/chemical synthesis , Pyrazines/chemical synthesis , Receptors, Glycine/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Animals , Anticonvulsants/chemical synthesis , Anticonvulsants/chemistry , Anticonvulsants/metabolism , Anticonvulsants/pharmacology , Cells, Cultured , Cerebellum/cytology , Cerebral Cortex/metabolism , Excitatory Amino Acid Antagonists/chemistry , Excitatory Amino Acid Antagonists/metabolism , Excitatory Amino Acid Antagonists/pharmacology , In Vitro Techniques , Long-Term Potentiation/drug effects , Mice , Neurons/drug effects , Neurons/physiology , Patch-Clamp Techniques , Pyrazines/chemistry , Pyrazines/metabolism , Pyrazines/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Glycine/metabolism , Receptors, Glycine/physiology , Receptors, N-Methyl-D-Aspartate/metabolism , Receptors, N-Methyl-D-Aspartate/physiology , Stereoisomerism
6.
Bioorg Med Chem Lett ; 10(10): 1133-7, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10843235

ABSTRACT

A novel series of 2-substituted-4,5-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives was synthesised. One of them, 4e-a highly water soluble compound exhibited a nanomolar affinity and demonstrated competitive antagonist properties at the ionotropic AMPA receptors. This compound also displayed potent anticonvulsant properties against electrically or sound-induced convulsions in mice after systemic administration, thus suggesting adequate brain penetration.


Subject(s)
Anticonvulsants/chemistry , Anticonvulsants/pharmacology , Pyrazines/chemistry , Pyrazines/pharmacology , Receptors, AMPA/antagonists & inhibitors , Urea/analogs & derivatives , Animals , Anticonvulsants/metabolism , Drug Evaluation, Preclinical , Inhibitory Concentration 50 , Isoquinolines/chemistry , Isoquinolines/metabolism , Isoquinolines/pharmacology , Mice , Mice, Inbred DBA , Pyrazines/metabolism , Quinoxalines/chemistry , Quinoxalines/metabolism , Quinoxalines/pharmacology , Rats , Receptors, AMPA/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Structure-Activity Relationship , Tetrazoles/chemistry , Tetrazoles/metabolism , Tetrazoles/pharmacology , Urea/chemistry , Urea/metabolism , Urea/pharmacology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism
7.
Bioorg Med Chem Lett ; 10(6): 591-6, 2000 Mar 20.
Article in English | MEDLINE | ID: mdl-10741560

ABSTRACT

A novel series of readily water soluble 8-methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]++ +pyrazines were synthesized. The -10-yl acetic acid ((+)-3) and -10-carboxylidene (4) derivatives exhibit potent affinities (IC50=4 and 19 nM, respectively) and antagonist properties (IC50 = 2 and 3 nM, respectively) at the ionotropic AMPA receptor. These compounds also display anticonvulsant properties against both electrically and sound-induced convulsions in mice after ip, sc and iv administration with ED50 values between 0.9 and 11 mg/kg, thus suggesting adequate brain penetration.


Subject(s)
Excitatory Amino Acid Antagonists/chemical synthesis , Pyrazines/chemical synthesis , Receptors, AMPA/antagonists & inhibitors , Animals , Anticonvulsants/chemical synthesis , Anticonvulsants/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Isoquinolines/pharmacology , Mice , Oocytes/metabolism , Pyrazines/pharmacology , Quinoxalines/pharmacology , Receptors, N-Methyl-D-Aspartate/drug effects , Seizures/drug therapy , Seizures/genetics , Tetrazoles/pharmacology , Xenopus laevis
8.
Bioorg Med Chem Lett ; 10(24): 2749-54, 2000 Dec 18.
Article in English | MEDLINE | ID: mdl-11133083

ABSTRACT

The over-stimulation of excitatory amino acid receptors such as the glutamate AMPA receptor has been suggested to be associated with neurodegenerative disorders. Here we describe an original series of readily water soluble 4-oxo-imidazo[1,2-a] indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid derivatives. One of these compounds, 4f, exhibited nanomolar binding affinity, potent competitive antagonism at the ionotropic AMPA receptor and a long duration of anticonvulsant activity after administration by parenteral route in vivo.


Subject(s)
Anticonvulsants/chemical synthesis , Anticonvulsants/pharmacology , Heterocyclic Compounds, 4 or More Rings/chemical synthesis , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/antagonists & inhibitors , Animals , Anticonvulsants/metabolism , Brain/cytology , Brain/ultrastructure , Cell Membrane/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Routes , Excitatory Amino Acid Agonists , Heterocyclic Compounds, 4 or More Rings/pharmacology , Imidazoles/chemical synthesis , Imidazoles/metabolism , Imidazoles/pharmacology , Inhibitory Concentration 50 , Male , Mice , Mice, Inbred DBA , Oocytes/drug effects , Protein Binding , Pyrazines/chemical synthesis , Pyrazines/metabolism , Pyrazines/pharmacology , Rats , Receptors, AMPA/antagonists & inhibitors , Receptors, AMPA/metabolism , Seizures/drug therapy , Structure-Activity Relationship , Time Factors , Xenopus
9.
Bioorg Med Chem Lett ; 9(20): 2921-6, 1999 Oct 18.
Article in English | MEDLINE | ID: mdl-10571148

ABSTRACT

Original spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives were synthesised and led to the identification of 3e which showed good affinities for both the AMPA and the NMDA glycine-site receptors, and displayed good anticonvulsant effects after i.p. and i.v. administrations in the electroshock-induced convulsion assay in mice. The corresponding dextrorotatory isomer (+)-3e was notably more potent than the levorotatory isomer (-)-3e in in vitro and in vivo assays.


Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Glycine/metabolism , Pyrazines/pharmacology , Receptors, AMPA/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Spiro Compounds/pharmacology , Animals , Binding Sites , Excitatory Amino Acid Antagonists/chemistry , Excitatory Amino Acid Antagonists/metabolism , Mice , Pyrazines/chemistry , Pyrazines/metabolism , Receptors, AMPA/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Spiro Compounds/chemistry , Spiro Compounds/metabolism , Structure-Activity Relationship
10.
Bioorg Med Chem ; 3(2): 129-41, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7540921

ABSTRACT

This paper describes the design and synthesis of a new class of molecules, the 3-sulfonylamino-2-(1H)-quinolones, which are potent and selective antagonists at both the AMPA/kainate site as well as at the NMDA-associated glycine site. The molecules were characterized by their binding affinities to rat cortical membranes and by electrophysiology on Xenopus oocytes injected with mRNA isolated from rat cerebral cortex. The most potent compound 61 has an IC50 of 0.09 microM for binding at the AMPA/kainate site, and 0.16 microM in oocyte electrophysiology.


Subject(s)
Excitatory Amino Acid Antagonists/pharmacology , Glycine/antagonists & inhibitors , Kainic Acid/antagonists & inhibitors , Quinolones/pharmacology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/antagonists & inhibitors , Animals , Binding, Competitive , Electrophysiology , Excitatory Amino Acid Antagonists/chemical synthesis , Excitatory Amino Acid Antagonists/chemistry , Molecular Structure , Oocytes/metabolism , Quinolones/chemical synthesis , Quinolones/chemistry , RNA, Messenger/genetics , Receptors, AMPA/antagonists & inhibitors , Receptors, Glutamate/biosynthesis , Receptors, Glutamate/metabolism , Receptors, Glycine/antagonists & inhibitors , Receptors, Kainic Acid/antagonists & inhibitors , Structure-Activity Relationship , Xenopus
11.
Eur J Pharmacol ; 247(3): 257-65, 1993 Nov 15.
Article in English | MEDLINE | ID: mdl-8307099

ABSTRACT

Diazoxide (100-560 microM) reversibly increased the amplitude and duration of excitatory post-synaptic field potentials recorded in the dentate gyrus of hippocampal slices following stimulation of the perforant pathway. In rat cortex mRNA-injected Xenopus oocytes diazoxide (1-1000 microM) alone had little effect on membrane current, but rapidly and reversibly increased (up to 5-fold) current responses to (R,S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA, 30 microM), L-glutamate (100 microM), quisqualate (3 microM), kainate (100 microM) and domoate (3 microM), an effect that was neither mimicked by other activators of ATP-sensitive potassium channels nor blocked by glibenclamide. Diazoxide increased current amplitudes for all concentrations of the 'inactivating' ligands, AMPA, L-glutamate and quisqualate but had little effect on their EC50 values. In contrast, diazoxide increased the apparent potency of the 'non-inactivating' ligands, kainate and domoate, but increased the efficacy of saturating concentrations by only 10-20%. Diazoxide did not modify the competitive inhibition of AMPA and kainate currents by 6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione (NBQX) and thus does not compete for the agonist site as do AMPA and kainate. Similarly, diazoxide neither inhibited the binding of [3H]AMPA or [3H]kainate to rat cortical membranes in competition experiments nor consistently modified the apparent [3H]AMPA affinity (Kd) or receptor density (Bmax) in saturation experiments. These data suggest that diazoxide acts at an allosteric site on the AMPA receptor/channel to potentiate activation in a manner dependent upon the properties of the excitatory agonist.


Subject(s)
Diazoxide/pharmacology , Hippocampus/drug effects , Receptors, AMPA/antagonists & inhibitors , Synapses/drug effects , Allosteric Regulation , Animals , Glycine/pharmacology , Hippocampus/physiology , In Vitro Techniques , Kinetics , Male , Membrane Potentials/drug effects , N-Methylaspartate/pharmacology , Oocytes/metabolism , RNA, Messenger/metabolism , Rats , Rats, Inbred F344 , Rats, Wistar , Synapses/physiology , Xenopus , gamma-Aminobutyric Acid/pharmacology
12.
Eur J Pharmacol ; 215(2-3): 237-44, 1992 May 14.
Article in English | MEDLINE | ID: mdl-1382998

ABSTRACT

We evaluated the inhibitory potencies at excitatory amino acid receptors of 2,3-dihydroxy-7-sulfamoyl-benzo[f]quinoxaline (BQX) and its 6-nitro derivative, NBQX. Currents activated by kainate or (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) in two-electrode voltage-clamp recordings of Xenopus oocytes injected with rat cortex mRNA were inhibited by BQX and NBQX: the apparent Ki values versus kainate were 14 microM and 78 nM, respectively, and versus AMPA were 23 microM and 63 nM, respectively. Thus, to a degree even more marked than with other quinoxalinedione derivatives, 6-nitro substitution of BQX to yield NBQX increases potency (200-fold) at the non-NMDA ionotropic receptor, but does not confer selectivity for kainate or AMPA. Schild analysis of the NBQX inhibition of the kainate and AMPA currents yielded pA2 values of 7.17 +/- 0.05 and 7.05 +/- 0.10, respectively, and slopes near unity confirming the competitive nature of the inhibition. Neither BQX nor NBQX significantly inhibited the current activated by glycine plus NMDA. The selectivity ratio of NBQX (greater than 5000-fold) is by far the greatest of any quinoxalinedione derivative antagonist of the kainate/AMPA receptor. BQX and NBQX also inhibited the excitatory postsynaptic field potentials mediated by kainate/AMPA receptors in the CA1 region of hippocampal slices after stimulation of the Schaffer collateral-commissural pathways with IC50 values of 130 and 0.90 microM, respectively. The 10-fold differences between the IC50 values in hippocampal slices and the Ki values in Xenopus oocytes correlate closely with data for other quinoxalinedione derivative antagonists.


Subject(s)
Ion Channels/drug effects , Quinoxalines/pharmacology , Receptors, Neurotransmitter/antagonists & inhibitors , Animals , Electrophysiology , Evoked Potentials/drug effects , Hippocampus/cytology , Hippocampus/drug effects , In Vitro Techniques , Neurons/drug effects , Nitro Compounds/pharmacology , Oocytes/drug effects , Oocytes/metabolism , Pyramidal Tracts/cytology , Pyramidal Tracts/drug effects , RNA, Messenger/pharmacology , Rats , Receptors, AMPA , Receptors, Amino Acid/drug effects , Receptors, Amino Acid/metabolism , Receptors, Kainic Acid , Synapses/drug effects , Xenopus
13.
Mol Pharmacol ; 41(2): 337-45, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1371583

ABSTRACT

The inhibitory potencies at excitatory amino acid (EAA) receptors of 11 quinoxaline derivatives were evaluated in two-electrode voltage-clamp recordings of Xenopus oocytes injected with rat cortex mRNA. Currents activated by kainate or (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) in Xenopus oocytes were inhibited competitively by all the quinoxaline derivatives, with apparent Ki values ranging from 0.27 to 300 microM against kainate and from 0.25 to 137 microM against AMPA. An excellent correlation was observed between inhibitory potencies of the quinoxaline derivatives against kainate and AMPA currents, in support of the contention that in this preparation these two agonists act at a single site. All 11 quinoxaline derivatives also inhibited current activated by the combination of glycine and N-methyl-D-aspartate (NMDA), apparently acting at the glycine site, and did so over a narrower range of apparent Ki values (0.37-8.1 microM). The correlation between the quinoxalines' kainate/AMPA potencies and their glycine/NMDA potencies was relatively weak. Thus, the quinoxaline derivatives were all good antagonists of glycine/NMDA currents and displayed a greater range of potencies against kainate and AMPA. The inhibitory effects of the six quinoxaline derivatives most potent in the Xenopus oocyte experiments were also tested against the excitatory postsynaptic field potential (EPSFP) recorded in the pyramidal cell dendritic field of the CA1 region of hippocampal slices after stimulation of the Schaffer collateral-commissural pathways. In slices superfused with "normal" medium (containing 1 mM Mg2+), in which the EPSFP is mediated primarily by non-NMDA receptors, IC50 values correlated closely with the Ki values against kainate/AMPA obtained in oocyte experiments but were approximately 8-fold higher. Similarly, in slices superfused with nominally Mg(2+)-free medium, in which the EPSFP is amplified due to a relief of the Mg2+ block of NMDA receptors, IC50 values correlated closely with the Ki values against glycine/NMDA obtained in oocyte experiments but were 60-fold higher. This comparison of results from the two experimental systems lends further support to the argument that hippocampal synaptic transmission is mediated postsynaptically by kainate/AMPA-type and NMDA/glycine-type EAA receptors that are pharmacologically indistinguishable from those expressed in mRNA-injected Xenopus oocytes. Furthermore, it suggests that EAA receptors in situ may be nearly saturated by high local concentrations of the endogenous ligands, a condition that would contribute substantially to the apparent non-NMDA receptor selectivity of certain quinoxaline derivatives.


Subject(s)
Quinoxalines/pharmacology , Receptors, Cell Surface/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Synapses/drug effects , Animals , Cells, Cultured , Cerebral Cortex/physiology , Electrophysiology , Evoked Potentials/drug effects , Female , Glycine/pharmacology , Hippocampus/anatomy & histology , Hippocampus/drug effects , Hippocampus/physiology , Ibotenic Acid/analogs & derivatives , Ibotenic Acid/antagonists & inhibitors , Ibotenic Acid/pharmacology , Kainic Acid/antagonists & inhibitors , Kainic Acid/pharmacology , Male , Membrane Potentials/drug effects , N-Methylaspartate/antagonists & inhibitors , N-Methylaspartate/pharmacology , Oocytes/drug effects , Oocytes/physiology , Oocytes/ultrastructure , RNA, Messenger/genetics , Rats , Rats, Inbred Strains , Receptors, Amino Acid , Receptors, Cell Surface/genetics , Structure-Activity Relationship , Synapses/physiology , Synapses/ultrastructure , Xenopus , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
14.
Br J Pharmacol ; 103(3): 1795-801, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1718524

ABSTRACT

1. The sensitivity of cromakalim-activated current (Icrom) to manipulations of extracellular cationic composition was examined in whole-cell voltage clamp recordings from freshly-dispersed, adult guinea-pig ventricular myocytes. In bathing media with different concentrations of K+ (1, 2.5, 5.4 and 12 mM) the Icrom reversal potential (Erev) varied in strict correspondance with the K+ equilibrium potential and inward Icrom amplitude was proportional to the external K+ concentration. 2. Replacement of 12mM K+ with 12mM Rb+ induced a slight positive shift of Erev indicating that PRb+/PK+ = 1.06. K+ replacement with 12mM Cs+ reduced or abolished inward Icrom and produced a negative shift of Erev by at least 50 mV; an upper limit of PCs+/PK+ was fixed at 0.18. 3. Addition of Rb+ (1-30 mM) to 2.5 mM K(+)-containing medium produced a concentration-dependent increase in inward Icrom and positive shift of Erev suggesting that K+ and Rb+ have similar permeabilities and conductivities and do not interfere with each other in the channel. 4. CS+ (0.01-30 mM), added to medium containing 12 mM Rb+, induced a potent, voltage-dependent inhibition of inwardly rectifying current (IK1; IC50 = 0.2-3 mM). Voltage-dependent inhibition of inward Icrom was observed only at considerably higher CS+ concentrations (IC50 = 4-30 mM). Extracellular Rb+ and CS+ did not substantially alter the amplitude of outward Icrom. 5. The results support the contention that the ATP-sensitive K+ channel is the primary target of cromakalim action in ventricular myocytes.


Subject(s)
Benzopyrans/pharmacology , Cations/metabolism , Cesium/pharmacology , Ion Channels/drug effects , Myocardium/metabolism , Pyrroles/pharmacology , Animals , Cesium/metabolism , Cromakalim , Electrophysiology , Guinea Pigs , Heart Ventricles/cytology , Heart Ventricles/metabolism , In Vitro Techniques , Membrane Potentials/drug effects , Myocardium/cytology , Potassium Channels/drug effects , Rubidium/metabolism
15.
J Cardiovasc Pharmacol ; 17(2): 348-50, 1991 Feb.
Article in English | MEDLINE | ID: mdl-1709243

ABSTRACT

S11568, (+-)[((amino-2-ethoxy)-2-ethoxy]-methyl)-2-(dichloro-2', 3'-phenyl)-4-ethoxycarbonyl-3-methoxycarbonyl-5-methyl-6-dihydro-1,4-pyr idine HCl, is a new dihydropyridine derivative that is water soluble and relatively insensitive to light. The Ca2+ channel inhibitory activity of S11568 was tested in whole-cell patch clamp recordings from cultured embryonic chick cardiomyocytes in 40 mM Ba2(+)-containing medium that revealed T-type and L-type components of inward current through calcium channels. S11568 inhibited L-type Ca2+ current with an IC50 value near 1 microM but was without effect on the T-type barium current.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Dihydropyridines/pharmacology , Animals , Barium/physiology , Chick Embryo , Heart/drug effects , Heart/embryology
16.
Eur J Pharmacol ; 190(1-2): 85-96, 1990 Nov 06.
Article in English | MEDLINE | ID: mdl-1706275

ABSTRACT

Biochemical and electrophysiological techniques were used to describe the Ca2+ channel blocking properties of a new dihydropyridine derivative, S11568 (+/-)- ([(amino-2-ethoxy)-2-ethoxy]methyl)-2-(dichloro-2',3'-phenyl)-4- ethoxy-carbonyl-3-methoxycarbonyl-5-methyl-6-dihydro-1,4-pyridine and its enantiomers S12967 ((+)-S11568) and S12968 ((-)-S11568). In binding studies, S11568 and S12968 displaced specifically bound [3H]PN 200-110 from cardiac and vascular smooth muscle preparations with potencies of 5.6-51 nM, respectively. S12967 was 6- to 18-fold less potent than S12968. A good correlation was found between the IC50 value for the inhibition of 45Ca2+ uptake by A7r5 aortic smooth muscle cells and binding data. Whole-cell patch clamp studies in both guinea-pig ventricular myocytes and A7r5 cells yielded similar results. At holding potential (VH) -50 mV, S12968 inhibited L-type Ca2+ current with an IC50 value near 70 nM, 2- to 3-fold more potently than S11568 and 30-fold more potently than S12967. With VH -100 mV, all three compounds were less potent, with IC50 values ranging from 500 nM to 3 microM. These results demonstrate conclusively that S12968 is the more active enantiomer. Furthermore, the pronounced voltage dependence of its actions in vitro suggests that in vivo it could exhibit good selectivity for vascular smooth muscle over cardiac muscle.


Subject(s)
Calcium Channel Blockers/pharmacology , Dihydropyridines/pharmacology , Heart/drug effects , Muscle, Smooth, Vascular/drug effects , 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology , Animals , Binding, Competitive/drug effects , Calcium Radioisotopes , Cell Line , Dihydropyridines/metabolism , Electrophysiology , Guinea Pigs , In Vitro Techniques , Inosine Triphosphate/metabolism , Isradipine , Male , Myocardium/cytology , Myocardium/metabolism , Oxadiazoles/pharmacology , Rats , Ryanodine/metabolism , Stereoisomerism
17.
Can J Physiol Pharmacol ; 68(8): 1069-78, 1990 Aug.
Article in English | MEDLINE | ID: mdl-1697218

ABSTRACT

Following injection of rat striatal and cerebrellar mRNA, Xenopus oocytes were voltage clamped and current responses to the excitatory amino acid receptor agonist, kainate, were recorded. This nonspecific cationic current is carried principally by Na+ and K+ and reverses polarity at a membrane potential of approximately -5 mV. When the membrane potential was voltage clamped to -60 mV, bath-applied tetrabutylammonium (0.1-30 mM) produced a rapid, concentration dependent and reversible block of kainate-induced inward current with an IC50 of 1.3 mM. Tetraalkylammonium derivatives having shorter chains (methyl, ethyl, and propyl) were relatively ineffective blockers. Longer alkyl chain derivatives (pentyl, hexyl, and heptyl) were more potent than tetrabutylammonium but limited in their usefulness by their toxicity. The antagonism of kainate-induced current by tetrabutylammonium displayed apparently uncompetitive kinetics, in contrast with the competitive antagonism by gamma-D-glutamylaminomethylsulfonate. The block by tetrabutylammonium was strongly voltage dependent; an e-fold change in IC50 was observed for a 27 mV change in holding potential. Replacement of the Na+ in the medium with a more permeant cation (NH4+), a less permeant cation (tetramethylammonium), or an uncharged solute (mannitol) had little effect on the block of kainate-induced current by tetrabutylammonium. The rates of association and dissociation of tetrabutylammonium with the kainate receptor-channel are clearly rapid. These observations suggest that tetrabutylammonium enters and blocks the kainate receptor-associated cation selective channel. Tetrabutylammonium appears to traverse 80-90% of the membrane electrical field to reach a relatively low-affinity binding site that may simply be a narrowing of the channel.


Subject(s)
Brain Chemistry/drug effects , Ion Channels/drug effects , Kainic Acid/metabolism , Oocytes/metabolism , Quaternary Ammonium Compounds/pharmacology , RNA, Messenger/pharmacology , Xenopus/metabolism , Animals , Binding Sites/drug effects , Binding, Competitive/drug effects , Electrophysiology , Male , Membrane Potentials/drug effects , Oocytes/drug effects , Potassium/metabolism , Potassium/pharmacology , Rats , Rats, Inbred Strains , Sodium/metabolism , Sodium/pharmacology
18.
Brain Res Bull ; 20(6): 771-7, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3044523

ABSTRACT

In vivo extracellular recordings from rat supraoptic and paraventricular magnocellular neurosecretory cells (MNCs) indicate that putative vasopressin-secreting MNCs may be identified by an abrupt and brief cessation in firing consequent to a transient drug-induced rise in arterial pressure sufficient to activate arterial baroreceptors. In the diagonal band of Broca (DBB), a population of neurons projecting towards the supraoptic nucleus are activated during this drug-induced hypertension. Electrical stimulation in DBB selectively depresses supraoptic vasopressin-secreting MNCs. Intracellular recordings in perfused hypothalamic explants confirm a DBB-evoked bicuculline-sensitive and chloride-dependent postsynaptic inhibition, similar to that associated with the application of gamma-aminobutyric acid (GABA) in approximately half of supraoptic MNCs. Since bicuculline also selectively blocks baroreceptor-induced inhibition in supraoptic MNCs, it is proposed that the depressant baroreflex input to vasopressin-secreting MNCs involves a population of DBB neurons and GABAergic interneurons located close to MNCs. An excitatory and selective input to vasopressin-secreting MNCs follows chemoreceptor activation, possibly mediated by the A1 noradrenergic cell group in the ventrolateral medulla. Another excitatory input to both vasopressin- and oxytocin-secreting MNCs is triggered by circulating angiotensin II and appears to be relayed centrally through an angiotensinergic projection from the subfornical organ.


Subject(s)
Cardiovascular Physiological Phenomena , Chemoreceptor Cells/physiology , Hypothalamus/physiology , Pressoreceptors/physiology , Action Potentials/drug effects , Animals , Hypothalamus/metabolism , Oxytocin/metabolism , Rats , Vasopressins/metabolism
19.
Mol Cell Biochem ; 80(1-2): 121-32, 1988.
Article in English | MEDLINE | ID: mdl-2459596

ABSTRACT

The properties of kainate receptor/channels were studied in Xenopus oocytes injected with mRNA that was isolated from adult rat striatum and cerebellum and partially purified by sucrose gradient fractionation. Kainate (3-1000 microM) induced a smooth inward current that was competitively inhibited by gamma-D-glutamyl-aminomethanesulfonate (GAMS, 300 microM). In striatal mRNA-injected oocytes, the kainate current displayed nearly linear voltage-dependence and mean reversal potential (Er) of -6.1 +/- 0.5 mV. In cerebellar mRNA-injected oocytes; Er was nearly identical (-5.1 +/- 1.2 mV) but there was marked inward rectification of the kainate current. Ion replacement studies reveal that the kainate channel is selective for cations over anions, but relatively non-selective among small monovalent cations. Large monovalent cations such as tetrabutylammonium are impermeant and induce a non-competitive block of kainate current that is strongly voltage-dependent. Divalent cations are relatively impermeant in the kainate channel and Cd++ and other polyvalent metals were shown to block kainate current by a mechanism that is only weakly voltage-dependent. A model of the kainate channel is proposed based upon these observations.


Subject(s)
Brain/metabolism , Glutamine/analogs & derivatives , Ion Channels/physiology , Oocytes/physiology , RNA, Messenger/metabolism , Receptors, Neurotransmitter/physiology , Animals , Cations/physiology , Cerebellum/metabolism , Corpus Striatum/metabolism , Electric Stimulation , Glutamates/pharmacology , In Vitro Techniques , Ion Channels/drug effects , Ion Channels/metabolism , Male , Oocytes/metabolism , Rats , Rats, Inbred Strains , Receptors, Kainic Acid , Receptors, Neurotransmitter/drug effects , Receptors, Neurotransmitter/genetics , Tetraethylammonium Compounds/pharmacology , Xenopus laevis
20.
J Physiol ; 387: 629-47, 1987 Jun.
Article in English | MEDLINE | ID: mdl-3656185

ABSTRACT

1. Intracellular recordings were obtained from thirty-eight rat supraoptic nucleus (s.o.n.) neurosecretory neurones in perfused hypothalamic explants. Changes in membrane potential and conductance were monitored following application of gamma-aminobutyric acid (GABA), and related agonists and antagonists. 2. GABA depressed action potential discharge of all of thirty-five s.o.n. neurones tested and induced either membrane hyperpolarization or depolarization. Neurones that displayed membrane hyperpolarization in response to lower GABA concentrations (30-300 microM) demonstrated a biphasic membrane voltage change with a later depolarizing phase as a response to higher concentrations (up to 3000 microM). 3. GABA (10-3000 microM) induced a prominent concentration-dependent increase in membrane conductance in all neurones. The critical slope for the log-log plot of [GABA] vs. GABA-induced membrane conductance was 1.7, indicating co-operativity in the GABA receptor-induced conductance change. 4. Muscimol (0.3-30 microM) potently mimicked all the effects of GABA. Bicuculline (1-100 microM) antagonized the effects of GABA and muscimol in a competitive manner. 5. Glycine and taurine (1-10 mM) had weak effects, although comparatively similar to those of GABA. These actions were blocked both by bicuculline (100 microM) and by strychnine (1 microM). At higher concentrations (greater than 10 microM), strychnine also antagonized the actions of GABA. 6. In recordings with potassium-acetate-filled micropipettes, the reversal potential of hyperpolarizing membrane voltage responses to GABA was -72.5 +/- 1.5 mV in close agreement (+/- 5 mV) with the reversal potential of inhibitory post-synaptic potentials (i.p.s.p.s) recorded in the same neurones. Depolarizing responses to GABA reversed polarity at -50 +/- 1.6 mV. In recordings with KCl-filled micropipettes, voltage responses to GABA were always depolarizing and reversed near -40.0 +/- 4.3 mV. Similarly, reduction of the concentration of chloride ions in the perfusion medium from 134 to 10.4 mM induced a positive shift of the GABA reversal potential by 40-50 mV. 7. From measurements of input resistance (Rin) and cell time constant (tau O), input capacitance (Cin; representing total membrane capacitance) was calculated as 78.9 +/- 2.1 pF. During responses to GABA or muscimol, decreased Rin was accompanied by a linearly related decrease in tau o indicating that these substances had no effect on the membrane capacitance of s.o.n. neurones.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Neurons/drug effects , Supraoptic Nucleus/physiology , gamma-Aminobutyric Acid/pharmacology , Action Potentials/drug effects , Animals , Bicuculline/pharmacology , Electric Conductivity , Glycine/pharmacology , In Vitro Techniques , Male , Membrane Potentials/drug effects , Muscimol/pharmacology , Rats , Rats, Inbred Strains , Strychnine/pharmacology , Taurine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...